Use of preclinical models to improve treatment of retinoblastoma.
Dyer
Michael A
MA
Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America. michael.dyer@stjude.org
Rodriguez-Galindo
Carlos
C
Wilson
Matthew W
MW
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D016923:Cell Death; D049109:Cell Proliferation; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D010641:Phenotype; D019572:Retinal Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D012175:Retinoblastoma / Q000503:physiopathology* / Q000628:therapy*
D000970:Antineoplastic Agents